Nuventra Pharma Sciences, a United States-based clinical pharmacology consulting company, has named Daniel Roy, MHA as its new president, it was reported on Tuesday.
Roy joined the company in 2014 as manager of Marketing and Corporate Communication. He has served in various roles of increasing responsibility including senior director of Business Development and Marketing, and most recently as vice president of Corporate Strategy and Business Development. He has 16 years of experience in leadership, marketing, and business development. He will continue to serve as the company's chief executive officer.
Roy graduated from Ohio University with a Master of Healthcare Administration and acquired a Bachelor of Arts degree in Communication from East Carolina University.
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head